K120236

Substantially Equivalent

TRANSFERRIN KIT FOR USE ON THE SPAPLUS

Applicant: The Binding Site Group , Ltd.
Product code: DDG
Advisory panel: Immunology
Date received: 2012-01-26
Decision date: 2013-02-13
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Birmingham, GB

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.